| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d7e470e09803bd6bf24b2fd176109dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aab07859a8ca849a187f461f04151354
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5434616e90ece4c2ba88ff212d7ab9c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5073a0063d6be9e25c14d2af0a1ee89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d08eb7bcc891c1f938e1c42d6006a21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbd8a0db9b949e2df1a013fd04037f9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d931bebade37471d936e3cad0c2ef39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48b9f1e1f432eecc4ce07c7125234085 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2003-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a59e54fa1b6950bd9814f231756411a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbe1ec9d286072ddd430453c48f8a837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a8ae84c92466a56d65482bf0d11ec74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9228ee0e26b10c243f8a5c8f9787d6c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd53c25521bc2ab0782d7bcd80e0d74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_687638b1818cdc730634d98341e8fa91 |
| publicationDate |
2004-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004035826-A1 |
| titleOfInvention |
Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease |
| abstract |
The invention relates to an in vitro method for determining the risk of developing thrombosis in a subject, and to an in vitro method for determining sensitivity of a subject toward a thienopyridine therapy. Both methods involve identifying a particular haplotype of the P2Y12 receptor gene. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101374956-B |
| priorityDate |
2002-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |